Global CRISPR Genome Editing Market Size, Status and Forecast 2020-2026

This report focuses on the global CRISPR Genome Editing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR Genome Editing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics

Market segment by Type, the product can be split into
Genetic Engineering
Gene Library
Human Stem Cells
Others
Market segment by Application, split into
Biotechnology Companies
Pharmaceutical Companies
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CRISPR Genome Editing status, future forecast, growth opportunity, key market and key players.
To present the CRISPR Genome Editing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of CRISPR Genome Editing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
1.4 Market Analysis by Type
1.4.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Genetic Engineering
1.4.3 Gene Library
1.4.4 Human Stem Cells
1.4.5 Others
1.5 Market by Application
1.5.1 Global CRISPR Genome Editing Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 CRISPR Genome Editing Market Perspective (2015-2026)
2.2 CRISPR Genome Editing Growth Trends by Regions
2.2.1 CRISPR Genome Editing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR Genome Editing Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR Genome Editing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 CRISPR Genome Editing Market Growth Strategy
2.3.6 Primary Interviews with Key CRISPR Genome Editing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top CRISPR Genome Editing Players by Market Size
3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2015-2020)
3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2015-2020)
3.1.3 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CRISPR Genome Editing Market Concentration Ratio
3.2.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2019
3.3 CRISPR Genome Editing Key Players Head office and Area Served
3.4 Key Players CRISPR Genome Editing Product Solution and Service
3.5 Date of Enter into CRISPR Genome Editing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global CRISPR Genome Editing Historic Market Size by Type (2015-2020)
4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2021-2026)

5 CRISPR Genome Editing Breakdown Data by Application (2015-2026)
5.1 Global CRISPR Genome Editing Market Size by Application (2015-2020)
5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America CRISPR Genome Editing Market Size (2015-2020)
6.2 CRISPR Genome Editing Key Players in North America (2019-2020)
6.3 North America CRISPR Genome Editing Market Size by Type (2015-2020)
6.4 North America CRISPR Genome Editing Market Size by Application (2015-2020)

7 Europe
7.1 Europe CRISPR Genome Editing Market Size (2015-2020)
7.2 CRISPR Genome Editing Key Players in Europe (2019-2020)
7.3 Europe CRISPR Genome Editing Market Size by Type (2015-2020)
7.4 Europe CRISPR Genome Editing Market Size by Application (2015-2020)

8 China
8.1 China CRISPR Genome Editing Market Size (2015-2020)
8.2 CRISPR Genome Editing Key Players in China (2019-2020)
8.3 China CRISPR Genome Editing Market Size by Type (2015-2020)
8.4 China CRISPR Genome Editing Market Size by Application (2015-2020)

9 Japan
9.1 Japan CRISPR Genome Editing Market Size (2015-2020)
9.2 CRISPR Genome Editing Key Players in Japan (2019-2020)
9.3 Japan CRISPR Genome Editing Market Size by Type (2015-2020)
9.4 Japan CRISPR Genome Editing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia CRISPR Genome Editing Market Size (2015-2020)
10.2 CRISPR Genome Editing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CRISPR Genome Editing Market Size by Type (2015-2020)
10.4 Southeast Asia CRISPR Genome Editing Market Size by Application (2015-2020)

11 India
11.1 India CRISPR Genome Editing Market Size (2015-2020)
11.2 CRISPR Genome Editing Key Players in India (2019-2020)
11.3 India CRISPR Genome Editing Market Size by Type (2015-2020)
11.4 India CRISPR Genome Editing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America CRISPR Genome Editing Market Size (2015-2020)
12.2 CRISPR Genome Editing Key Players in Central & South America (2019-2020)
12.3 Central & South America CRISPR Genome Editing Market Size by Type (2015-2020)
12.4 Central & South America CRISPR Genome Editing Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Editas Medicine
13.1.1 Editas Medicine Company Details
13.1.2 Editas Medicine Business Overview and Its Total Revenue
13.1.3 Editas Medicine CRISPR Genome Editing Introduction
13.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2015-2020))
13.1.5 Editas Medicine Recent Development
13.2 CRISPR Therapeutics
13.2.1 CRISPR Therapeutics Company Details
13.2.2 CRISPR Therapeutics Business Overview and Its Total Revenue
13.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
13.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020)
13.2.5 CRISPR Therapeutics Recent Development
13.3 Horizon Discovery
13.3.1 Horizon Discovery Company Details
13.3.2 Horizon Discovery Business Overview and Its Total Revenue
13.3.3 Horizon Discovery CRISPR Genome Editing Introduction
13.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2015-2020)
13.3.5 Horizon Discovery Recent Development
13.4 Sigma-Aldrich
13.4.1 Sigma-Aldrich Company Details
13.4.2 Sigma-Aldrich Business Overview and Its Total Revenue
13.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
13.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2015-2020)
13.4.5 Sigma-Aldrich Recent Development
13.5 Genscript
13.5.1 Genscript Company Details
13.5.2 Genscript Business Overview and Its Total Revenue
13.5.3 Genscript CRISPR Genome Editing Introduction
13.5.4 Genscript Revenue in CRISPR Genome Editing Business (2015-2020)
13.5.5 Genscript Recent Development
13.6 Sangamo Biosciences
13.6.1 Sangamo Biosciences Company Details
13.6.2 Sangamo Biosciences Business Overview and Its Total Revenue
13.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
13.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
13.6.5 Sangamo Biosciences Recent Development
13.7 Lonza Group
13.7.1 Lonza Group Company Details
13.7.2 Lonza Group Business Overview and Its Total Revenue
13.7.3 Lonza Group CRISPR Genome Editing Introduction
13.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2015-2020)
13.7.5 Lonza Group Recent Development
13.8 Integrated DNA Technologies
13.8.1 Integrated DNA Technologies Company Details
13.8.2 Integrated DNA Technologies Business Overview and Its Total Revenue
13.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
13.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2015-2020)
13.8.5 Integrated DNA Technologies Recent Development
13.9 New England Biolabs
13.9.1 New England Biolabs Company Details
13.9.2 New England Biolabs Business Overview and Its Total Revenue
13.9.3 New England Biolabs CRISPR Genome Editing Introduction
13.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2015-2020)
13.9.5 New England Biolabs Recent Development
13.10 Origene Technologies
13.10.1 Origene Technologies Company Details
13.10.2 Origene Technologies Business Overview and Its Total Revenue
13.10.3 Origene Technologies CRISPR Genome Editing Introduction
13.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2015-2020)
13.10.5 Origene Technologies Recent Development
13.11 Transposagen Biopharmaceuticals
10.11.1 Transposagen Biopharmaceuticals Company Details
10.11.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue
10.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
10.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2015-2020)
10.11.5 Transposagen Biopharmaceuticals Recent Development
13.12 Thermo Fisher Scientific
10.12.1 Thermo Fisher Scientific Company Details
10.12.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
10.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
10.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2015-2020)
10.12.5 Thermo Fisher Scientific Recent Development
13.13 Caribou Biosciences
10.13.1 Caribou Biosciences Company Details
10.13.2 Caribou Biosciences Business Overview and Its Total Revenue
10.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
10.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
10.13.5 Caribou Biosciences Recent Development
13.14 Precision Biosciences
10.14.1 Precision Biosciences Company Details
10.14.2 Precision Biosciences Business Overview and Its Total Revenue
10.14.3 Precision Biosciences CRISPR Genome Editing Introduction
10.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
10.14.5 Precision Biosciences Recent Development
13.15 Cellectis
10.15.1 Cellectis Company Details
10.15.2 Cellectis Business Overview and Its Total Revenue
10.15.3 Cellectis CRISPR Genome Editing Introduction
10.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2015-2020)
10.15.5 Cellectis Recent Development
13.16 Intellia Therapeutics
10.16.1 Intellia Therapeutics Company Details
10.16.2 Intellia Therapeutics Business Overview and Its Total Revenue
10.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
10.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020)
10.16.5 Intellia Therapeutics Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables

Table 1. CRISPR Genome Editing Key Market Segments
Table 2. Key Players Covered: Ranking by CRISPR Genome Editing Revenue
Table 3. Ranking of Global Top CRISPR Genome Editing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CRISPR Genome Editing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Genetic Engineering
Table 6. Key Players of Gene Library
Table 7. Key Players of Human Stem Cells
Table 8. Key Players of Others
Table 9. Global CRISPR Genome Editing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global CRISPR Genome Editing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global CRISPR Genome Editing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global CRISPR Genome Editing Market Share by Regions (2015-2020)
Table 13. Global CRISPR Genome Editing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global CRISPR Genome Editing Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. CRISPR Genome Editing Market Growth Strategy
Table 19. Main Points Interviewed from Key CRISPR Genome Editing Players
Table 20. Global CRISPR Genome Editing Revenue by Players (2015-2020) (Million US$)
Table 21. Global CRISPR Genome Editing Market Share by Players (2015-2020)
Table 22. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2019)
Table 23. Global CRISPR Genome Editing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR Genome Editing Product Solution and Service
Table 26. Date of Enter into CRISPR Genome Editing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 29. Global CRISPR Genome Editing Market Size Share by Type (2015-2020)
Table 30. Global CRISPR Genome Editing Revenue Market Share by Type (2021-2026)
Table 31. Global CRISPR Genome Editing Market Size Share by Application (2015-2020)
Table 32. Global CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 33. Global CRISPR Genome Editing Market Size Share by Application (2021-2026)
Table 34. North America Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 35. North America Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 36. North America CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 37. North America CRISPR Genome Editing Market Share by Type (2015-2020)
Table 38. North America CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 39. North America CRISPR Genome Editing Market Share by Application (2015-2020)
Table 40. Europe Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 42. Europe CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 43. Europe CRISPR Genome Editing Market Share by Type (2015-2020)
Table 44. Europe CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 45. Europe CRISPR Genome Editing Market Share by Application (2015-2020)
Table 46. China Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 47. China Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 48. China CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 49. China CRISPR Genome Editing Market Share by Type (2015-2020)
Table 50. China CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 51. China CRISPR Genome Editing Market Share by Application (2015-2020)
Table 52. Japan Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 54. Japan CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 55. Japan CRISPR Genome Editing Market Share by Type (2015-2020)
Table 56. Japan CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 57. Japan CRISPR Genome Editing Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 60. Southeast Asia CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia CRISPR Genome Editing Market Share by Type (2015-2020)
Table 62. Southeast Asia CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia CRISPR Genome Editing Market Share by Application (2015-2020)
Table 64. India Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 65. India Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 66. India CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 67. India CRISPR Genome Editing Market Share by Type (2015-2020)
Table 68. India CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 69. India CRISPR Genome Editing Market Share by Application (2015-2020)
Table 70. Central & South America Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 72. Central & South America CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America CRISPR Genome Editing Market Share by Type (2015-2020)
Table 74. Central & South America CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America CRISPR Genome Editing Market Share by Application (2015-2020)
Table 76. Editas Medicine Company Details
Table 77. Editas Medicine Business Overview
Table 78. Editas Medicine Product
Table 79. Editas Medicine Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 80. Editas Medicine Recent Development
Table 81. CRISPR Therapeutics Company Details
Table 82. CRISPR Therapeutics Business Overview
Table 83. CRISPR Therapeutics Product
Table 84. CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 85. CRISPR Therapeutics Recent Development
Table 86. Horizon Discovery Company Details
Table 87. Horizon Discovery Business Overview
Table 88. Horizon Discovery Product
Table 89. Horizon Discovery Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 90. Horizon Discovery Recent Development
Table 91. Sigma-Aldrich Company Details
Table 92. Sigma-Aldrich Business Overview
Table 93. Sigma-Aldrich Product
Table 94. Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 95. Sigma-Aldrich Recent Development
Table 96. Genscript Company Details
Table 97. Genscript Business Overview
Table 98. Genscript Product
Table 99. Genscript Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 100. Genscript Recent Development
Table 101. Sangamo Biosciences Company Details
Table 102. Sangamo Biosciences Business Overview
Table 103. Sangamo Biosciences Product
Table 104. Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 105. Sangamo Biosciences Recent Development
Table 106. Lonza Group Company Details
Table 107. Lonza Group Business Overview
Table 108. Lonza Group Product
Table 109. Lonza Group Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 110. Lonza Group Recent Development
Table 111. Integrated DNA Technologies Business Overview
Table 112. Integrated DNA Technologies Product
Table 113. Integrated DNA Technologies Company Details
Table 114. Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 115. Integrated DNA Technologies Recent Development
Table 116. New England Biolabs Company Details
Table 117. New England Biolabs Business Overview
Table 118. New England Biolabs Product
Table 119. New England Biolabs Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 120. New England Biolabs Recent Development
Table 121. Origene Technologies Company Details
Table 122. Origene Technologies Business Overview
Table 123. Origene Technologies Product
Table 124. Origene Technologies Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 125. Origene Technologies Recent Development
Table 126. Transposagen Biopharmaceuticals Company Details
Table 127. Transposagen Biopharmaceuticals Business Overview
Table 128. Transposagen Biopharmaceuticals Product
Table 129. Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 130. Transposagen Biopharmaceuticals Recent Development
Table 131. Thermo Fisher Scientific Company Details
Table 132. Thermo Fisher Scientific Business Overview
Table 133. Thermo Fisher Scientific Product
Table 134. Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 135. Thermo Fisher Scientific Recent Development
Table 136. Caribou Biosciences Company Details
Table 137. Caribou Biosciences Business Overview
Table 138. Caribou Biosciences Product
Table 139. Caribou Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 140. Caribou Biosciences Recent Development
Table 141. Precision Biosciences Company Details
Table 142. Precision Biosciences Business Overview
Table 143. Precision Biosciences Product
Table 144. Precision Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 145. Precision Biosciences Recent Development
Table 146. Cellectis Company Details
Table 147. Cellectis Business Overview
Table 148. Cellectis Product
Table 149. Cellectis Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 150. Cellectis Recent Development
Table 151. Intellia Therapeutics Company Details
Table 152. Intellia Therapeutics Business Overview
Table 153. Intellia Therapeutics Product
Table 154. Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 155. Intellia Therapeutics Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Genome Editing Market Share by Type: 2020 VS 2026
Figure 2. Genetic Engineering Features
Figure 3. Gene Library Features
Figure 4. Human Stem Cells Features
Figure 5. Others Features
Figure 6. Global CRISPR Genome Editing Market Share by Application: 2020 VS 2026
Figure 7. Biotechnology Companies Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Others Case Studies
Figure 10. CRISPR Genome Editing Report Years Considered
Figure 11. Global CRISPR Genome Editing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global CRISPR Genome Editing Market Share by Regions: 2020 VS 2026
Figure 13. Global CRISPR Genome Editing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global CRISPR Genome Editing Market Share by Players in 2019
Figure 16. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by CRISPR Genome Editing Revenue in 2019
Figure 18. North America CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Editas Medicine Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 27. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CRISPR Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 29. Horizon Discovery Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Horizon Discovery Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 31. Sigma-Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sigma-Aldrich Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 33. Genscript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Genscript Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 35. Sangamo Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sangamo Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 37. Lonza Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Lonza Group Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 39. Integrated DNA Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Integrated DNA Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 41. New England Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. New England Biolabs Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 43. Origene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Origene Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 45. Transposagen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Transposagen Biopharmaceuticals Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 47. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 49. Caribou Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Caribou Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 51. Precision Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Precision Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 53. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cellectis Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 55. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Intellia Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

$3900.00
$7800.00

Don't have an account and you don't want to register? Checkout as a guest instead!